Literature DB >> 8695967

Influence of age and body mass on the effects of vitamin D on hip fracture risk.

J Ranstam1, J A Kanis.   

Abstract

The role of vitamin D in the prevention of hip fracture is controversial and protective effects appear to be confined to the institutionalized and elderly population. The aim of this study was to assess the interaction of age and body mass index (BMI) on the effects of vitamin D on the risk of hip fracture in the community. We studied 1634 women with low-energy fractures of the hip aged 50 years or older, and 3532 age-matched controls from 14 centres in six Mediterranean countries (the MEDOS study), with a structured retrospective questionnaire. The use of vitamin D supplements was associated with a modest and non-significant decrease in the risk of hip fracture (RR = 0.74; 95% confidence interval (CI) 0.53-1.03; p = 0.07). The risk reduction was influenced by age and body mass. Women aged above 80 years had a significant decrease in the relative risk of hip fracture (RR = 0.63; 95% CI 0.40-0.98) as did women with a BMI below 20 kg/m2 (RR = 0.45; 95% CI 0.24-0.84). Elderly women were more likely to have a low BMI but the elderly did not appear to benefit from vitamin D where their BMI was 20 kg/m2 or higher. The findings could not be explained by differences in sun exposure or in physical exercise. We conclude that the use of vitamin D for the prevention of hip fracture might usefully be targeted to the frail and elderly.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8695967     DOI: 10.1007/bf01626607

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  14 in total

1.  Bone density parathyroid hormone and 25-hydroxyvitamin D concentrations in middle aged women.

Authors:  K T Khaw; M J Sneyd; J Compston
Journal:  BMJ       Date:  1992-08-01

2.  Calcitriol treatment is not effective in postmenopausal osteoporosis.

Authors:  S M Ott; C H Chesnut
Journal:  Ann Intern Med       Date:  1989-02-15       Impact factor: 25.391

3.  Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study.

Authors:  J C Gallagher; D Goldgar
Journal:  Ann Intern Med       Date:  1990-11-01       Impact factor: 25.391

4.  Prevention of bone loss in postmenopausal and senile osteoporosis with vitamin D analogues.

Authors:  J C Gallagher
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

5.  The Mediterranean Osteoporosis (MEDOS) Study questionnaire.

Authors:  J Dequeker; J Ranstam; J Valsson; B Sigurgevisson; E Allander
Journal:  Clin Rheumatol       Date:  1991-03       Impact factor: 2.980

6.  Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitamin D3 and calcium.

Authors:  G F Jensen; C Christiansen; I Transbøl
Journal:  Clin Endocrinol (Oxf)       Date:  1982-05       Impact factor: 3.478

7.  Vitamin D3 and calcium to prevent hip fractures in elderly women.

Authors:  M C Chapuy; M E Arlot; F Duboeuf; J Brun; B Crouzet; S Arnaud; P D Delmas; P J Meunier
Journal:  N Engl J Med       Date:  1992-12-03       Impact factor: 91.245

8.  Calcitriol in the treatment of postmenopausal osteoporosis.

Authors:  J F Aloia; A Vaswani; J K Yeh; K Ellis; S Yasumura; S H Cohn
Journal:  Am J Med       Date:  1988-03       Impact factor: 4.965

9.  Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture.

Authors:  J A Kanis; O Johnell; B Gullberg; E Allander; G Dilşen; C Gennari; A A Lopes Vaz; G P Lyritis; G Mazzuoli; L Miravet
Journal:  BMJ       Date:  1992-11-07

10.  Reduced occurrence of vertebral crush fractures in senile osteoporosis treated with 1 alpha (OH)-vitamin D3.

Authors:  H Orimo; M Shiraki; T Hayashi; T Nakamura
Journal:  Bone Miner       Date:  1987-10
View more
  5 in total

1.  Treatment of osteoporosis with vitamin D.

Authors:  J A Kanis; E V McCloskey; D de Takats; J Bernard; D M Zhang
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

Review 2.  Vitamin D and analogues in renal bone disease and implications for osteoporosis.

Authors:  J A Kanis; E V McCloskey; M N Beneton
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

3.  Efficacy of optimization of vitamin D in preventing osteoporosis and osteoporotic fractures: A systematic review.

Authors:  Kazutoshi Nakamura; Masayuki Iki
Journal:  Environ Health Prev Med       Date:  2006-07       Impact factor: 3.674

4.  Latitude, socioeconomic prosperity, mobile phones and hip fracture risk.

Authors:  O Johnell; F Borgstrom; B Jonsson; J Kanis
Journal:  Osteoporos Int       Date:  2006-11-01       Impact factor: 4.507

5.  Effects of cyclical etidronate combined with calcitriol versus cyclical etidronate alone on spine and femoral neck bone mineral density in postmenopausal osteoporotic women.

Authors:  T Masud; B Mulcahy; A V Thompson; S Donnelly; R W Keen; D V Doyle; T D Spector
Journal:  Ann Rheum Dis       Date:  1998-06       Impact factor: 19.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.